PDMR Notification RSU Vesting
PureTech Health plc announced that a person discharging managerial responsibilities, Eric Elenko, received 112,509 ordinary shares on March 12, 2026, following the vesting of restricted share units granted on May 22, 2023. The shares were issued at a price of 0.01 GBP each, based on an average closing price of 123.67 pence per share over the three trading days prior to the vesting date of March 11, 2026. After this issuance, the company's total issued ordinary share capital stands at 257,927,489 shares.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PDMR Notifications
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announces that the award of restricted share units ("RSUs") granted by PureTech on 22 May 2023 to a certain person discharging managerial responsibilities ("PDMR") pursuant to its Performance Share Plan ("PSP") vested on 11 March 2026 following satisfaction of certain performance conditions measured over the three year period to 31 December 2025.
The PDMR received vested ordinary shares (after deduction of shares for payroll taxes) on 12 March 2026. The market price per ordinary share in the Company used to calculate the amount payable to the PDMR and the amount of shares to be issued to the PDMR was 123.67 pence, being the average closing price of the Company's shares over the three-trading day period immediately preceding the vesting date, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.34.
The Company's total issued ordinary share capital is 257,927,489 shares after the share issuance to the PDMR, 14,859,738 shares of which are held in treasury by the Company.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Eric Elenko |
| 2 | Reason for the notification | |
| a) | Position/status | President |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| c) | Price(s) and volume(s) | Recipient Price Amount Eric Elenko 0.01 GBP 112,509 ordinary shares |
| e) | Date of the transaction | 12 March 2026 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.